ImmuCell Corporation
ICCC
$6.20
-$0.05-0.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.76M | -271.70K | -2.16M | -3.81M | -4.05M |
| Total Depreciation and Amortization | 2.69M | 2.70M | 2.69M | 2.69M | 2.71M |
| Total Amortization of Deferred Charges | 43.20K | 43.20K | 42.60K | 41.90K | 39.80K |
| Total Other Non-Cash Items | 112.30K | 166.60K | 191.20K | 259.40K | 382.60K |
| Change in Net Operating Assets | -2.08M | -1.12M | -406.50K | 459.30K | 682.80K |
| Cash from Operations | 2.53M | 1.51M | 357.90K | -362.10K | -230.60K |
| Capital Expenditure | -768.90K | -724.40K | -465.70K | -350.80K | -682.90K |
| Sale of Property, Plant, and Equipment | 29.20K | 4.50K | 4.50K | 4.50K | 6.90K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 115.10K | 0.00 |
| Cash from Investing | -739.60K | -719.90K | -461.20K | -231.20K | -676.10K |
| Total Debt Issued | -- | -- | -- | 0.00 | 4.00M |
| Total Debt Repaid | -1.50M | -1.49M | -1.47M | -1.45M | -3.41M |
| Issuance of Common Stock | 4.74M | 4.83M | 4.81M | 4.02M | 436.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -359.70K | -499.60K | -461.60K | -153.20K | -251.30K |
| Cash from Financing | 2.88M | 2.85M | 2.88M | 2.41M | 776.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.67M | 3.64M | 2.78M | 1.82M | -130.00K |